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Co-crystallisation of cytosine with 1,10-phenanthroline: 
computational screening and experimental realisation 
 
Abstract 
Attempts to co-crystallise the nucleobases adenine, thymine, guanine, and cytosine with 
1,10-phenanthroline by ball milling and solvent evaporation methods are described. A 1:1 
co-crystal of cytosine and 1,10-phenanthroline can be obtained by grinding or by solvent 
evaporation. The structure contains two crystallographically independent cytosine and two 
independent 1,10-phenanthroline molecules (Zʹ=2). The cytosine molecules form two similar 
but crystallographically independent hydrogen-bonded chains, while the 1,10-phenanthroline 
molecules are arranged in π-stacks. Between the chains of cytosine and the π-stacks exist 
N−H···N and C−H···N interactions. Crystal structure prediction (CSP) calculations were applied 
to all four systems to assess their potential for co-crystallisation as well as the likely structures 
and intermolecular interactions that could result from co-crystallisation. Calculations on the 
cytosine system demonstrate that co-crystallisation results in a lower energy than the 
crystalline forms of the two starting materials, in line with the co-crystal formation observed. 
For the systems which did not form a co-crystal, CSP was used to explore potential packing 
arrangements, but found none which were lower in energy than that of the pure crystalline 
forms. In these cases there is significant disruption to the nucleobase hydrogen bonding 
between the pure compound and the hypothetical co-crystal. For pure adenine and guanine, the 
hydrogen-bonded ribbons form sheets which must be broken, whereas for thymine, the lack of 
hydrogen donors does not allow the hydrogen bonding present for pure thymine to be 
maintained while forming thymine-1,10-phenanthroline hydrogen bonds.  
 
 









The physical properties of molecular solids are inextricably linked with the arrangements of 
individual molecules in the crystal.1 Any change in the overall crystal structure, such as the 
inclusion of a water molecule or proton migration, causes changes in the intermolecular 
interactions in the crystal. Such alteration in the intermolecular interactions and the crystal 
packing normally results in a change in physical properties.  
Crystal engineering2, 3 may be defined as the rational design of crystalline solids through control 
of intermolecular interactions. A promising route to improving physical properties of a solid is 
co-crystallisation of a given compound with another neutral compound which is a solid at 
ambient conditions.  Hence, co-crystals have gained attention within the crystal engineering 
field due to the interest in modifying the physical properties of a compound.4 For example, in 
the pharmaceutical industry co-crystallisation has shown potential to alter the solubility, 
bioavailability, dissolution, and physiochemical stability of active pharmaceutical ingredients 
(APIs).5 Drug candidates that display poor solubility present a major challenge in the 
pharmaceutical industry and hence many APIs are prepared as hydrates or salts. However, co-
crystallisation is also an important area to explore for the improvement of properties.  
A classic example is the case of sildenafil or Viagra, which was initially used for addressing 
angina, high blood pressure or pulmonary hypertension, but was subsequently targeted for 
treating erectile dysfunction. In the Viagra formulation, the active ingredient sildenafil is 
present as a citrate salt, which is only moderately soluble.6 However, a remarkable increase in 
the solubility was observed when sildenafil was co-crystallised with acetylsalicylic acid.7  
Similarly, co-crystallisation of melamine with cyanuric acid has a profound effect on solubility. 
Toxicological studies of both melamine and cyanuric acid showed no effect on the kidney 
function of cats fed on melamine and cyanuric acid individually.8 However, intratubular 
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precipitation of highly insoluble co-crystals of melamine:cyanuric acid causes acute renal failure 
in cats.  
As part of a programme to explore the hydrogen bonding capability of DNA nucleobases, we 
investigated co-crystallisation of these with suitable co-formers. These are good candidates for 
co-crystallisation because of their versatile hydrogen bonding functionality.9-16 Co-
crystallisation of DNA bases has been demonstrated for a wide range of commercially available 
co-formers including other DNA bases, carboxylic acids, or N-donor bases.12, 17 
A survey of the Cambridge Structural Database18 (CSD version 5.35, November 2013) shows 
that nucleobases can display a range of different hydrogen bonding motifs. A good example of 
this flexibility is the base pairing between DNA bases which can follow either the Watson-
Crick19 or Hoogsteen20 modes of hydrogen bonding. However, structures involving cytosine 
frequently display hydrogen-bonded chains of molecules as shown Figure 1a. 
In this work we describe attempts to form co-crystals of the DNA bases (cytosine, adenine, 
thymine and guanine) with 1,10-phenanthroline (1,10-phen), to explore whether the hydrogen-
bond acceptor properties of 1,10-phen would make it a suitable co-former. Experimental 
studies ran parallel to computational crystal structure prediction (CSP) studies, whose aim was 
to explore the potential crystal packing of co-crystals of 1,10-phen with the DNA bases, and to 
assess the potential of CSP to predict the outcome of co-crystallisation experiments. The results 
of crystal structure determinations and CSP calculations are presented.  
 




Figure 1: Comparison of synthons: a) synthon formation between two cytosine molecules; b) 




Reagents and purities 
All chemicals were obtained from Alfa Aesar and used without further purification. Purity of 
reagents is as follows: 1,10-phenanthroline hydrate 99%, Adenine 99%, Guanine 98%, Cytosine 
98%, Thymine 97%. 
Co-crystal screening 
In order to explore the formation of co-crystals between DNA bases and the 1,10-phen, we 
employed solid-state neat grinding21 methods described in literature.22 Binary mixtures of                
1,10–phenanthroline  hydrate (0.1982 g, 1 mmol) with DNA bases [Cytosine (0.111 g, 1 mmol), 
Adenine (0.135 g, 1 mmol), Thymine (0.126 g, 1 mmol), Guanine (0.151 g, 1 mmol)] were 
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prepared. These were transferred to a 12 mL jar and milled for 1 hour under neat condition in a 
Retsch PM 100 ball mill. Two stainless steel balls of 10mm diameter were used for milling.  
Single Crystal Preparation 
1,10-phenanthroline hydrate (0.1982 g, 1 mmol) and the DNA base [Cytosine (0.027 g, 0.25 
mmol); Adenine (0.034 g, 0.25 mmol); Thymine (0.032 g, 0.25 mmol); Guanine (0.038 g, 0.25 
mmol)] were dissolved in 50% ethanol:water (20mL) and stirred for 10 min with gentle 
heating. The solution was allowed to evaporate slowly at room temperature.  
Infra-red (IR) Spectroscopy  
FT-IR spectra were collected from samples prepared as KBr disks (1:20 dilution) using a Perkin 
Elmer FT-IR Spectrometer Spectrum RX1.  
Single Crystal X-ray Diffraction Measurements 
Single crystal X-ray diffraction data were collected in series of ω-scans using a Stoe IPSD2 image 
plate diffractometer utilising monochromated Mo Kα radiation (λ = 0.71073 Å). Integration and 
processing of the data were performed using standard procedures in X-RED.23 Samples were 
coated in a thin film of perfluoropolyether oil and mounted on a goniometer. An Oxford 
Cryosystems nitrogen gas cryostream was used to control the temperature during the 
diffraction experiment, which was set to 100 K.  
The crystal structure was solved using routine automatic Direct Methods implemented within 
SHELXS-97.24 Completion of the structure was achieved by performing least squares refinement 
against all unique F2 values using SHELXL-97.24 All non-H atoms were refined with anisotropic 
displacement parameters. Location of hydrogen atoms was achieved by using difference Fourier 
maps.  
X-ray Powder Diffraction  
Relatively high resolution X-ray powder diffraction data were collected from intimately ground 
samples mounted on a PANAlytical Empyrean diffractometer operating with a Cu Kα1 radiation 
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and a PIXCel deterctor. Rietveld25 refinement was carried out within the GSAS26 suite of 
programs. The background was fitted using a 6-term shifted Chebyshev function. The unit cell 
parameters and a zero point error were refined. A single Gaussian peak shape parameter was 
refined. No atoms positions were refined; a single isotropic displacement parameter was refined 
for all non-H atoms and Uiso (H) was set to 0.05 Å2.  
 
Computational Methods  
To characterise the potential energy surface of the four systems, and to assess the utility of CSP 
for co-crystal screening, CSP calculations were undertaken prior to having seen the 
experimental results. CSP is usually addressed as a lattice energy minimisation problem, whose 
process involves three general steps:27 calculation of the molecular geometry; generation of trial 
co-crystal structures and lattice energy minimisation of these co-crystal structures. The 
assumption is that the lowest energy computer-generated possibilities represent the most likely 
crystal structures. As an extension to this idea, prediction of whether a co-crystal will form in 
preference to pure phases of the constituent molecules is performed by comparing the 
calculated lattice energy of the most stable predicted co-crystal structures to the sum of the 
pure phase lattice energies28. A lower co-crystal lattice energy than the pure components 
represents an energetic driving force for co-crystallisation. 
Gas-phase geometries of all molecules (1,10-phen and the four bases), were optimised at the 
B3LYP29, 30/ 6-311G** level of Kohn-Sham theory, using the Gaussian09 program.31 Using these 
molecular structures, crystal structures were generated with one of each molecule per 
asymmetric unit in 12 common space groups (P1, P-1, P21, C2, Cc, P21/c, C2/c, P212121, Pca21, 
Pna21, Pbcn, Pbca) with the Global Lattice Energy Explorer (GLEE)32, 33 code. The method applies 
a quasi-random structure generation with rigid molecular geometries, using a Sobol sequence 
for the quasi-random numbers. Within each space group, lattice parameters are sampled with 
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the constraint of giving a reasonable starting volume, then each molecule in the asymmetric unit 
is placed with a quasi-random position and orientation, with no constraints on relative 
positioning of the two components apart from rejection of trial structures with overlapping 
molecules. 10,000 trial structures were generated for each system in each space group. These 
were relaxed to minimise their lattice energies using the DMACRYS34 crystal structure 
modelling program, followed by removal of duplicate structures using the COMPACK 
algorithm35, comparing inter-atomic separations within 30 molecule clusters from each crystal 
structure. The unique structures were then ranked by stability according to their final 
calculated lattice energy. The intermolecular force-field comprised an exp-6 repulsion-
dispersion function, using a revised version36 of Williams’ empirically parameterised W99 
potential37, and an electrostatic model derived using a distributed multipole analysis38 of the 
B3LYP-6311G** electron density, including atomic multipoles up to the rank of hexadecapole on 
each atom. Charge-charge, charge-dipole and dipole-dipole interactions were summed using 
Ewald summation, which all other interactions were summed to a cut-off of 15 Å. Space group 
symmetry was constrained during lattice energy minimisation. The resulting 100 lowest energy 
predicted structures, for each of the four co-crystal combinations, are available in CIF format as 
supplementary information.  
For the experimentally observed co-crystal structure of 1,10-phen and cytosine, and for all 
structures of pure systems, the procedure of minimising the gas-phase molecular structure and 
then the crystal structure was again followed, all at the same level of theory as used in the 
prediction calculations, in order to make comparisons between the experimentally observed 
and theoretical structures. The relevant structures of the pure crystals, with the following 
reference codes in parentheses, were taken from the CSD: 1,10-phen (OPENAN39), adenine 
(KOBFUD40), cytosine (CYTSIN41), guanine (KEMDOW42) and thymine (THYMIN43). In the case of 
guanine all calculations were performed using the tautomer which appears in the pure guanine 
crystal structure. 




Results and Discussion 
Energetic prediction of co-crystallisation 
A primary goal of the calculations in this study was to assess the energetic driving force for co-
crystallisation of 1,10-phen with each of the four DNA bases.  The approach, proposed in a study 
of the urea : acetic acid complex28, has since been validated on larger sets of multicomponent 
crystals44, 45, 46 and recently used to guide the experimental realisation of previously 
unobtainable co-crystal of caffeine with benzoic acid47. The results of computational global 
lattice energy searches can be particularly informative in cases where an experimental crystal 
has not yet been observed, or even prior to performing any experiments, as CSP explores and 
characterises the structures which could potentially form. These calculations describe the 
underlying potential energy surface of the crystal in a way which is not dependent on 
experimental conditions such as solvent or temperature, and so can give an estimation of the 
fundamental energetic driving force for co-crystal formation. 
The results presented on this set of systems helps to further assess the approach, which could 
be used for computational co-crystal screening. The energies and densities of the lowest energy 
structures from our Zʹ=1 CSP study for the co-crystal systems are summarised in Figure 2. 
Calculated energies are also summarised in Table 1. 
With regards to the energetics of forming a co-crystal, we calculate that only one of the DNA 
bases, cytosine, benefits energetically by co-crystallisation with 1,10-phen (Figure 2b). We 
predict 19 distinct 1:1 co-crystal structures of cytosine with 1,10-phen with a more favourable 
lattice energy than the sum of the lattice energies of the cytosine and 1,10-phen single 
component structures. Any of these structures represents an energetic benefit of co-
crystallisation over crystallisation of the pure components. With the usual assumptions of 
crystal structure prediction, the lowest energy of these predicted co-crystals is judged as the 
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most likely observable co-crystal. The predicted structure is described in more detail below and 
all predicted structures are available in CIF format as supplementary information. Starting from 
their known crystal structures, we calculate the lattice energy of cytosine to be -125.77 kJ/mol, 
and 1,10-phen to be -91.95 kJ/mol; their sum (-217.72 kJ/mol) is shown as a dashed line in 
Figure 2b. The predicted co-crystal global minimum lies 7.54 kJ/mol lower in energy than the 
separate pure phases. None of the predicted co-crystal structures of adenine, guanine or 
thymine with 1,10-phen had a lattice energy which was below the sum of the individual pure 
crystals that comprised the co-crystal. In the case of adenine, the best predicted co-crystal is 
8.49 kJ/mol above the separate pure phases, which is a strong indication that adenine:1,10-
phen would not be observed, at least in the 1:1 stoichiometry investigated in the computational 
study. In the cases of guanine and thymine, co-crystal formation is associated with a very small 
loss in lattice energy of 0.23 and 0.20 kJ/mol respectively. Although we would not predict the 
formation of co-crystals of either base with 1,10-phen, these values are within any reasonable 
estimation of the error associated with lattice energy calculations. 
 
Figure 2: Lattice energy versus density is plotted for the lowest energy structures from the Zʹ=1 
CSP search for 1,10-phen with a) adenine, b) cytosine, c) guanine and d) thymine. The dashed 
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lines mark the sums of the lattice energies of the crystals of the two components in their pure 
crystal structures. For cytosine:1,10-phen, the global minimum in the set is circled by a solid 
line. The lattice energy minimised Zʹ=2, experimentally observed, structure is represented by 
the red circle.  
 
 
Energies in kJ/mol Adenine Cytosine Guanine Thymine 
E(Latt) pure expt. -135.13 -124.56 -161.30 -113.76 
base + 
1,10-phenanthroline 
-227.08 -217.72 -253.25 -205.71 
Lowest (Zʹ=1) CSP -218.59 -225.26 -253.02 -205.52 
Expt. co-crystal Not observed -226.06 Not observed Not observed 
Table 1. Calculated lattice energies for each pure crystal, added with that for 
1,10-phenanthroline, and compared to the lowest energy in the set of structures generated with 
a (Zʹ=1) CSP. In the case of cytosine:1,10-phen, this can be compared with the observed crystal. 
 
Co-crystal screening and PXRD analysis 
In terms of potential hydrogen bonding, all four DNA bases: adenine; cytosine; thymine and 
guanine might be predicted to form co-crystals with 1,10-phen. This hypothesis was based on 
the hydrogen bond donor sites present in all these bases that would enable them to interact 
with the basic nitrogens of 1,10-phen, forming N—H···N(pyridyl) interactions. However, the 
results of the screening experiments suggest that not all DNA bases do form co-crystals with 
1,10-phen. Powder X-ray diffraction data (PXRD) collected from the product of milling cytosine 
with 1,10-phen are shown in Figure 3. It is clear that characteristic peaks of cytosine and 
1,10-phen hydrate are no longer present in the pattern. For example, no major feature exists in 
the region around 2 = 20° in the product unlike patterns of each starting material. We were 
not able to identify any other known phase in the powder diffraction pattern.  




Figure 3: Simulated X-ray powder diffraction patterns of cytosine and 1,10-phenanthroline 
hydrate, and experimental pattern obtained after milling their mixture. 
 
For the other DNA bases, evidence that co-crystallisation has occurred with 1,10-phen during 
milling is much weaker. Little evidence of partial phase transformation was observed in the co-
crystallisation experiment between adenine and 1,10-phen. (Figure S1) These findings suggest 
that the PXRD pattern of the product of grinding is simply a mixture of the two starting 
materials. Figure S2 shows the X-ray powder diffraction pattern collected from the solid product 
of milling thymine with 1,10-phen. The diffraction pattern closely resembles a mixture of 
thymine and 1,10-phen hydrate. Although the emergence of small features in the region 8 ≤ 2θ/ 
° ≤ 12  suggest a new phase may be emerging, protracted grinding of this mixture (4 hours) did 
not lead to further changes in the powder diffraction pattern of the product. Finally, the results 
of the co-crystallisation between guanine and 1,10-phen are shown in Figure S3. The pattern of 
the milled product bears a close resemblance to that of 1,10-phen hydrate, but there are extra 
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features that do not appear to be consistent with pure guanine such as the broad peak at 
2 = 27°, shoulder at 2 = 14° and disappearance of guanine peaks at 2 = 13, 13.8	and	16.2°. 
Similar to the case of thymine, protracted grinding did not yield further changes in the 
diffraction pattern suggesting co-crystal formation was not occurring.  
 
Evaluation of the results from co-crystal screening and solution crystallisation 
The initial screening reactions by milling demonstrated a new phase had formed from the 
milling of cytosine and 1,10-phen. For brevity, hereafter we designate this phase cyt:phen. We 
were able to use solution methods to grow crystals from a mixture of cytosine and 1,10-phen 
hydrate. It proved possible to solve the structure by routine single-crystal X-ray methods.  
Screening experiments of 1,10-phen hydrate with adenine, thymine and guanine, respectively 
suggested that co-crystallisation has been unsuccessful. Remarkably, the only reaction which 
afforded single crystals is the reaction of cytosine with 1,10-phen hydrate, which is consistent 
with the formation of a new phase upon milling these two starting materials together.   
Structure of cyt:phen 
Colourless crystals were obtained by simple solvent evaporation and were determined to be a 
1:1 co-crystal with composition (C4H5N3O)2·(C12H8N2)2.† This phase cyt:phen crystallises in the 
monoclinic space group P21/c with a unit cell volume = 2722.99(5) Å3. The asymmetric unit 
contains two crystallographically independent cytosine molecules and two crystallographically 
independent 1,10-phen molecules (ie Zʹ = 2) as depicted in Figure 4.  
 




Figure 4: Asymmetric unit of cyt:phen. Atoms are drawn as 50% probability ellipsoids. Dashed 
lines represent N—H···N hydrogen bonds 
 
Chemically sensible criteria were imposed while analysing and identifying the hydrogen bond 
patterns in the structure. These include: all donors should have a covalent bond with a 
hydrogen atom, the hydrogen bond acceptors should possess a lone pair of electrons capable of 
forming hydrogen bonds, and the D—H···A angle > 90°, as classified by Jeffrey.48 
Each of the two independent cytosine molecules forms a zigzag hydrogen-bonded chain that 
extends parallel to the crystallographic b-axis. Chain 1 is composed only of the first cytosine 
molecule and likewise the second crystallographically-independent cytosine is only found in 
chain 2.  The chains are very similar and are sustained by pairs of  8
  embraces between 
symmetry-related cytosine molecules. (Figure 5)  




Figure 5: Chains formed by each crystallographically-independent cytosine.  
  
homosynthons are generated with symmetry equivalent counterparts of each cytosine with the 
following symmetry operations: : i=(-x, y-0.5,-z+1.5); ii=(-x, y+0.5,-z+1.5); iii=(-x+1, y-0.5,-
z+0.5); iv=(-x+1, y+0.5, z-0.5). 
 
The two symmetry-independent 1,10-phen molecules are arranged approximately parallel. The 
1,10-phen molecules are stacked along the crystallographic b-axis but they are inclined at an 
angle 46.2 (15)° to b. Within this π-stack the distances between π-systems alternate between 
3.38 (7) Å and 3.28 (8) Å. These separations are suggestive of a moderately strong interactions 
between the two π- systems. This pair of 1,10-phen molecules are part of an extended π-stack 
that is parallel to b-axis. The structure is thus divided into two structural elements: the 
hydrophilic part comprising hydrogen-bonded chains and the hydrophobic part comprising π-
stacked aromatic molecules. (Figure 6 and Figure 7) 




Figure 6: View of cyt:phen just off [010] direction illustrating infinite chains of cytosine and 
stacking of phenanthroline molecules 





Figure 7:  The stacking of phenanthroline: a) packing of phenanthroline viewed down [100]. 
Dashed lines indicate short π–π distances; b) & c) π–π stacking of 1,10-phenanthroline; the two 
symmetry-independent phenanthroline molecules are coloured differently. 
 
There are strong N−H···N and weaker C−H···N hydrogen bonds between the chains and the 
1,10-phen π-stacks. As shown in Figure 4, each 1,10-phen acts as a hydrogen bond acceptor to a 
cytosine molecule. The assembly of hydrophobic and hydrophilic parts of the structure by 
hydrogen bonds is illustrated in Figure 9a.  
Close examination of the structure reveals the presence of a weak hydrogen bond between 
cytosine and 1,10-phen molecule in the asymmetric unit. The interaction arises between C50—
H50(aromatic)···N3(endocyclic). The donor acceptor distance and the angle of this interaction 
are in compliance with the classification provided by Jeffrey.48 The distance was recorded as 
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3.511(4) Å and the angle was observed to be 150.5°. Full details of the hydrogen bonding 
present are shown in Table 2. 
 
D-H A d (D-H)/ (Ȧ) d (H···A) (Ȧ) d (D···A) (Ȧ) <D-H···A (°) 
N1-H1 N3i 0.86 1.94 2.792(3) 171.9 
N40-H40A O20ii 0.86 2.24 3.094(3) 170.4 
N40-H40B N42 0.86 2.16 3.012(3) 169.4 
C5-H5 N41 0.93 2.66 3.206(3) 118.1 
N44-H44A O21iii 0.86 2.26 3.116(3) 174.7 
N44-H44B N22 0.86 2.22 3.072(3) 168.9 
C15-H15 N21 0.93 2.63 3.147(3) 115.4 
N11-H11 N13iv 0.86 1.94 2.798(3) 173.5 
C50-H50 N3v 0.93 2.67 3.511(4) 150.5 
Table 2: Hydrogen bonding in cyt:phen. Symmetry equivalent atoms are generated by the 
following symmetry operations: i=(-x+1, y-0.5, -z+1.5); ii=(-x, y+0.5, -z+1.5); iii=(-x+1, y-0.5, -
z+0.5);  iv=(-x+1, y+0.5, -z+0.5); v=(-x, -y+2, -z+1). 
 
 
Phase purity and Rietveld fitting 
X-ray powder diffraction was used to determine whether the single crystal examined was 
representative of the phase obtained by ball milling. Data were collected from a 1:1 mixture of 
cyt:phen that had been milled for 1 hour. A partial Rietveld fit to this is shown in Figure 8. The 
initial model employed to fit the observed data was the structure determined from the single 
crystal at 100 K. Following refinement of the model, it is clear that the quality of fit to the 
observed data is good, as shown by Rp of 0.0918 for all data. There is no evidence for other 
crystalline phases present. It would be possible to improve the fit further by imposing 
appropriate restraints on the model and refining atom positions, but this would be very time-
consuming given the complexity of the model. The fit shown in Figure 8 demonstrates clearly 
that the cyt:phen co-crystal can be obtained pure by ball-milling of the two components and 
demonstrates the solution and ball-milling techniques produce the same co-crystal. ‡  
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The synthesis of cyt:phen by ball-milling was entirely reproducible. Experiments to prove the 
extent of reaction as a function of milling time were undertaken. After 30 minutes grinding 
there is little evidence of a transformation to the co-crystal, but 60 minutes grinding is sufficient 
to effect a full transformation (Figure S5). It is also possible to generate pure cyt:phen by hand 
grinding within an agate pestle and mortar for a period of 60 minutes. (Figure S6) 
 
Figure 8: Observed (×), calculated (line), and difference (lower line) X-ray powder diffraction 
profiles for cyt:phen at room temperature; tick marks indicate positions of allowed reflections 
from the Kα1 diffraction.  
 
Cyt:phen melted in the range 224-226 °C with some darkening. A small portion was melted 
between glass slides (at around 250 °C) and the product was examined by X-ray diffraction. (See 
supplementary information figures S7-8) X-ray diffraction data suggest the co-crystal 
decomposes on melting to give cytosine and 1,10-phen phases.  
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To explore whether the observed structure for cyt:phen would undergo a phase change upon 
heating, single-crystal X-ray diffraction data sets were collected at 293 K and 393 K. In each case 
the data unambiguously showed the presence of the same cell as that observed for cyt:phen at 
100 K. It was possible to refine structures at each temperature and despite thermal expansion of 
the unit cell there are no major structural changes between 100 K and 393 K. The ESI contains 
refined structures for 293 K and 393 K data.  
 
Packing of the predicted co-crystal structures 
The predictions from CSP are in good agreement with what has been observed in the co-
crystallisation studies. Cytosine:1,10-phen is the only co-crystal predicted to benefit 
significantly in lattice energy relative to the pure components and is the only system that 
unambiguously forms a co-crystal. In addition to this basic energetic evaluation, further analysis 
of the predicted crystal structures of all four systems provides additional insight into the 
interactions driving co-crystallisation.    
While the prediction of co-crystal formation agrees with experiment, none of the predicted co-
crystals of cytosine with 1,10-phen completely reproduces the packing the observed structure, 
since CSP was restricted to Zʹ=1 and the observed structure contains two formula units in the 
asymmetric unit. Lattice energy minimisation of the observed crystal structure shows that the 
observed Zʹ=2 packing is slightly (0.8 kJ/mol) more stable than the best Zʹ=1 predicted co-
crystal structure (Table 1 and Figure 2). Given that several predicted co-crystal structures lie 
close in energy to the observed co-crystal, and lower in energy than the pure components, 
polymorphism of this co-crystal could be possible under different crystallisation conditions 
such as different solvent, temperature or additives. 
Cytosine molecules show a clear preference to form planar, hydrogen bonded chains in the 
predicted co-crystal structures. The chains that are found in the observed co-crystal structure 
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(Figure 5) occur in 39 of the 42 computer generated structures that lie within 10 kJ/mol of the 
lowest energy Zʹ=1 calculated co-crystal structure. Co-crystal formation is stabilised by the 
ability of the remaining amine hydrogen to interact with the nitrogen atom of 1,10-phen, which 
lies at a variety of orientations relative to the cytosine chains in the predicted structures. While 
all molecules in the resulting cytosine:1,10-phen chains are co-planar in some of the low energy 
predicted structures, this is not the case in the Pbca Zʹ=1 global energy minimum. In this lowest 
energy structure, the 1,10-phen molecules are tilted out of the plane of the cytosine ribbons, 
allowing π-stacking in the direction of the cytosine-cytosine hydrogen bonds (see Figure 9b and 
d). The observed Zʹ=2 co-crystal structure (Figure 9a and c) has the same hydrogen bonding as 
seen in the lowest energy predicted structure. However, a different arrangement of the 1,10-
phen molecules along the π-stacking direction leads to more buckled hydrogen bonded layers 
(Figure 9d) in the predicted structure.  A pseudo-screw axis in the observed structure alternates 
the orientation of 1,10-phen molecules along their π-stacking direction; a similar arrangement 
is seen in the lowest energy Zʹ=1 structure in the P21/c space group, although the overall 
packing of this structure is less dense than others of comparable lattice energy.  




Figure 9: The observed Zʹ=2 structure (a and c) is compared with the structure with the lowest 
energy in the Zʹ=1 CSP (b and d). a and b are viewed perpendicular to the hydrogen bonded 
sheets, whereas the point of view of c and d is at an angle of  90° from this. Blue dashed lines 
between molecules represent hydrogen bonds.  




Figure 10: Hydrogen bonding arrangement in the lowest energy predicted co-crystal structures 
of a) adenine, b) guanine and c) thymine with 1,10-phenanthroline. 
 
Our understanding of why cytosine is the only base to co-crystallise with 1,10-phen is enhanced 
by consideration of the packing motifs of the known pure component crystal structures versus 
those suggested as potential co-crystals in the CSP. Hydrogen-bonded ribbons formed by the 
bases along a true or approximate 21 screw are seen throughout the known crystal structures of 
all four nucleobases, as well as the predictions for all four co-crystal systems, including in the 
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lowest structure of all sets apart from thymine:1,10-phen (Figure 10). Interactions with 
1,10-phen replace the connection between the ribbons in the pure nucleobases, which depend 
on the remaining hydrogen-bond donor and acceptors of the base. The 1,10-phen molecule is 
observed at various angles to the nucleobase chains in the predicted co-crystal structures. In 
pure cytosine (CSD refcode CYTSIN), the ribbons are not co-planar and there is only one 
hydrogen bond cross-connection per molecule between ribbons; this can be favourably replaced 
by the cytosine-1,10-phen hydrogen bonding to form a co-crystal. Cytosine maintains its 
hydrogen bond count in the co-crystal, while 1,10-phen gains relative to its pure phase.  
Hydrogen bond ribbons of the bases with two rings, adenine and guanine, align to form sheets 
in their pure crystal structures (KOBFUD and KEMDOW, respectively). In both cases, their pure 
phases satisfy all possible hydrogen bond donors and acceptors, but two inter-ribbon hydrogen 
bonds in the pure nucleobase crystal structures are replaced by a single base-1,10-phen 
hydrogen bond in the best possible co-crystal structure. This loss of hydrogen bonding is 
compensated by the gain by 1,10-phen of a hydrogen bond compared to its pure form. The 
predicted co-crystals of these two systems form buckled hydrogen bond sheets, in which π-
stacking is poor. Overall, the energetics balance out for guanine, with the best co-crystal being 
nearly equi-energetic with the pure phases. Adenine loses out more dramatically in its 
hypothetical co-crystal, leaving one of its nitrogen atoms uninvolved in any hydrogen bonding. 
The resulting energy loss (Table 1) makes co-crystallisation in this system very unlikely.  
Thymine, on the other hand, has an excess of hydrogen bond acceptors and the ribbons in the 
pure structure (THYMIN) do not have hydrogen bonds between them which would have to be 
broken in order to form the co-crystal. However, 1,10-phen, as a hydrogen bond acceptor, 
cannot interact favourably with the unused acceptor on thymine. Instead, the ribbons are 
replaced by thymine dimers in the predicted co-crystal, which hydrogen bond to 1,10-phen. 
Again, hydrogen bonding of the base is poorer in the hypothetical co-crystal than the pure 
phase, while 1,10-phen gains a hydrogen bond in the co-crystal; these effects balance, so that 
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the predicted co-crystal represents neither an energetic gain nor a loss relative to the pure 
phases.  
These results give useful insight into the balance of interactions that influence whether a co-
crystal is formed. Whilst we believe that we have characterised the important interactions in 
these co-crystal systems, the observed Zʹ=2 structure of the cyt:phen co-crystal reminds us that 
not all possibilities have been sampled in the CSP studies. Symmetry lowering between the 
experimentally observed Zʹ=2 P21/c cyt:phen, and the lowest energy Zʹ=1 Pbca may be worth 
around 0.8 kJ/mol. In the gua:phen and thy:phen cases the lattice energy penalty of co-crystal 
formation was less than this; it is possible that more stable co-crystal structures exist in high Zʹ 
or space groups that were not considered. However, for CSP to be a useful tool in screening 
candidates, it must be fast, and so we restricted our search to Zʹ=1 crystals. The implications of 
possible low symmetry structures provide a source of error, but also food for consideration 
when optimising a search in phase space. On the other hand, the stabilisation of the lowest Zʹ=1 
prediction of cyt:phen compared to its pure crystals, was roughly an order of magnitude larger 
than the energy of relaxing to the Zʹ=2 structure, and so we would be reasonably confident 
extending this methodology to making further blind predictions of co-crystallisation for systems 
such as these. 
 
Relationship of cyt:phen to other cytosine-containing compounds 
Evaluation of the cyt:phen structure and other cytosine-containing structures in the CSD sheds 
light on the rather flexible and versatile hydrogen bonding displayed by this compound. 
Hydrogen bond patterns were firstly compared with those observed in organic salts of cytosine.  




Figure 11: Representations of portions of crystal structures of cytosine and cytosinium 
compounds.  
 
It is evident from Figure 11 that in cytosinium dihydroxybenzoate the cytosinium cations 
interact with each other via only one hydrogen bond and the neighbouring molecules are 
tilted.49  In cytosinum maleate, the cytosinium cations form pairs of hydrogen bonds which 
generate a  8
  homosynthon.50 In this case, the cytosinium ribbon is interrupted by the 
maleate anion, which forms a  8
  heterosynthon with cytosinium on one side, and a single 
hydrogen bond on the other. Interestingly, the cytosinium ribbons in cytosinium isophthalate 
are held together via two distinct hydrogen bonding patterns. The first one is a  12
  
homosynthon and the second pattern is  8
  homosynthon.51 The latter is akin to the 
interaction observed in the cyt:phen structure.  
Hydrogen bond patterns of cyt:phen were also compared to co-crystals of cytosine (or its 
derivatives) reported in literature and retrieved from the CSD. It was noticed that there are 
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fewer co-crystals of cytosine or its derivatives compared to salt forms.  Figure 12 depicts the 
hydrogen bonding between the reported 5-fluorocytosine:terephthalic acid and cyt:phen. The 
findings on cytosine hydrogen bonding from the present study are in agreement with the 
findings of da Silva and co-workers.52 
 
Figure 12: Representations of portions of crystal structures of the co-crystals 
5-fluorocytosine:terephthalic acid and cyt:phen.  
 
However, contrary to the cytosine ribbon obtained in the cyt:phen co-crystal, co-crystals of 
cytosine:5-isopropyl-6-methylisocytosine (herein referred to as co-former) display a different 
hydrogen bonding motif. In the structure reported by Radhakrishnan et al.53 in 2014, cytosine is 
hydrogen bonded to the co-former via a similar motif to its base pairing with guanine in the 
DNA. It should also be noted that the G:C-like hydrogen bond between cytosine and its co-
former is stabilised by hydrogen bonding to the adjacent molecules which generate a  8
  
heterosynthon.  





Although each of the nucleobases examined has the potential to form N−H···N hydrogen bonds 
to 1,10-phen, it has only proved possible to obtain the co-crystal of 1,10-phen with cytosine. CSP 
studies have estimated the change in internal energy of a mixed system undergoing co-
crystallization, and only predict a favourable thermodynamic driving force in this case. 
Qualitative analysis of theoretically generated structures, and comparison with other known 
cytosine co-crystals has identified structural motifs which we believe to be important in these 
systems. In pure cytosine,  8
  embraces assemble the cytosine molecules into chains, or 
ribbons, and co-crystallisation with 1,10-phen does not disrupt this hydrogen-bonded chain 
significantly. It seems likely that it is the similarity in portions of the structures that explains the 
ease with which co-crystallisation occurs upon grinding. It is notable that this hydrogen-bonded 
chain of cytosine occurs in almost all of the lowest energy Zʹ=1 predicted structures. The 
observed structure contains this chain but the ABAB stacking of 1,10-phen has denser packing 
and a lower energy. 
For the other nucleobases, though, the computational study suggests that there is a more 
significant disruption to the nucleobase hydrogen bonding between the pure compound and the 
hypothetical co-crystal. In the cases of pure adenine and guanine, the ribbons form sheets which 
must be broken, whereas in that of thymine, the lack of hydrogen donors does not allow the 
hydrogen bonding present for pure thymine to be maintained while forming thymine-1,10-phen 
hydrogen bonds.  
It is clear that there must be a shift in the energetic balance of hydrogen bond breaking and 
making, and 1,10-phen stacking, for co-crystallization to occur in some cases compared to 
others. These experimental studies, comparisons to similar systems, and CSP predictions qualify 
and quantify the most favourable interactions in the set of nucleobases with this potential 
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partner. The combination of these has helped to rationalize the observed results, and provides 
information which can guide future candidates for co-crystallization.  
This study illustrates the insight that can be gained through combining computational methods 
of structure prediction with experimental solid form screening and characterisation. In the 
longer term, a goal for crystal structure prediction is to be used reliably in advance of 
experimental efforts, to guide the best choice of experiments. The complexity of the newly 
discovered co-crystal of cytosine with 1,10-phen, with four independent molecules in the 
crystallographic asymmetric unit, highlights one of the challenges for prediction methodologies. 
While the computational effort required to screen all crystal packing possibilities, including all 
reasonable space group and Zʹ combinations, is not unachievable, the timescales required using 
typical computational resources would currently be longer than would useful for screening sets 
of co-former possibilities. Nevertheless, the results of the present study show that even limited 
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† Crystal structure information for cyt:phen : Cytosine:Phenanthroline co-crystal (Zʹ=2), Mo Kα 
(λ = 0.71073 Å), 5269 independent reflections (Rint = 0.0993), T = 100 K, monoclinic, space 
group P21/c, a = 20.765(2) b = 9.4741(5) c = 14.1307(13) β = 101.612(8) °, V = 2723.0(4) Å3, ρ = 
1.421 g cm−3, F(000) = 1216, GooF = 0.867, R1 (I > 2σI) = 0.0646, wRF2 (I >2σI) = 0.1527. 
‡ Rietveld refinement information for cyt:phen : Cytosine:Phenanthroline co-crystal (Zʹ=2), Cu 
Kα1 (λ = 1.54056 Å), 2039 points, T = 293 K, monoclinic, space group P21/c, a = 20.694(4) b = 
9.4591(13) c = 14.381(3) Å β = 100.867(8) °, V = 2764.6(11) Å3. Uiso(non-H) = 0.038(5) Å2 Uiso 
(H) = 0.05 Å2. Rwp = 0.1296, Rp = 0.0918.  
 
Supplementary information 
CCDC 1048496 contains the supplementary crystallographic data for this paper. These data can 
be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif 
The ESI contains X-ray powder diffraction data relating to the co-crystallisation trials, and 
details of the 100 lowest-energy structures found from the CSP calculations. Crystal structures 
of cyt:phen collected at 293 K and 393 K.  
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Co-crystallisation of cytosine with 1,10-phenanthroline: 








Crystal structure prediction calculations applied to co-crystals of 1,10-phenanthroline and 
nucleobases (A, T, C, G) show that only cytosine is expected to form a 1:1 co-crystal. Experiments 
provide verification for this result although the observed co-crystal crystallises with Zʹ=2 rather than 
Zʹ=1.  
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